Kim Kelderman - Aug 5, 2023 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Pres. Diagnostics & Genom
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 5, 2023
Transactions value $
-$340,102
Form type
4
Date filed
8/8/2023, 05:28 PM
Previous filing
Aug 25, 2022
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $0 +8.06K +53.01% $0.00 23.3K Aug 5, 2023 Direct
transaction TECH Common Stock Tax liability -$340K -4.14K -17.79% $82.17 19.1K Aug 5, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Options Exercise $0 -8.06K -100% $0.00* 0 Aug 5, 2023 Common Stock 8.06K Direct F2, F3
holding TECH Stock Option (Right to Buy) 27.4K Aug 5, 2023 Common Stock 27.4K $37.70 Direct F1
holding TECH Stock Option (Right to Buy) 48.2K Aug 5, 2023 Common Stock 48.2K $44.33 Direct F1
holding TECH Stock Option (Right to Buy) 36.1K Aug 5, 2023 Common Stock 36.1K $44.33 Direct F1
holding TECH Stock Option (Right to Buy) 47.8K Aug 5, 2023 Common Stock 47.8K $47.60 Direct F1
holding TECH Stock Option (Right to Buy) 63.8K Aug 5, 2023 Common Stock 63.8K $47.60 Direct F1
holding TECH Stock Option (Right to Buy) 36K Aug 5, 2023 Common Stock 36K $66.97 Direct F1
holding TECH Stock Option (Right to Buy) 33.3K Aug 5, 2023 Common Stock 33.3K $66.97 Direct F1
holding TECH Stock Option (Right to Buy) 48K Aug 5, 2023 Common Stock 48K $66.97 Direct F4
holding TECH Restricted Stock Units 4.98K Aug 5, 2023 Common Stock 4.98K Direct F2, F5
holding TECH Stock Option (Right to Buy) 19.5K Aug 5, 2023 Common Stock 19.5K $120.46 Direct F5
holding TECH Stock Option (Right to Buy) 25.9K Aug 5, 2023 Common stock 25.9K $120.46 Direct F6
holding TECH Restricted Stock Units 6.98K Aug 5, 2023 Common Stock 6.98K Direct F2, F7
holding TECH Stock Options (Right to Buy) 21.7K Aug 5, 2023 Common Stock 21.7K $94.52 Direct F7
holding TECH Stock Options (Right to Buy) 28.9K Aug 5, 2023 Common Stock 28.9K $94.52 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully exercisable.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3 On 8/5/2023, the Board of Directors certified vesting of 8,060 performance RSUs.
F4 Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F5 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025.
F7 Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.

Remarks:

On November 28, 2022, the Company completed a four-for-one stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to November 28, 2022 have been adjusted to reflect the four-for-one stock split.